Your browser doesn't support javascript.
loading
Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.
Antonios, Joseph P; Soto, Horacio; Everson, Richard G; Moughon, Diana; Orpilla, Joey R; Shin, Namjo P; Sedighim, Shaina; Treger, Janet; Odesa, Sylvia; Tucker, Alexander; Yong, William H; Li, Gang; Cloughesy, Timothy F; Liau, Linda M; Prins, Robert M.
Afiliación
  • Antonios JP; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Soto H; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Everson RG; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Moughon D; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Orpilla JR; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Shin NP; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Sedighim S; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Treger J; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Odesa S; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Tucker A; Department of Neurosurgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Yong WH; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Li G; Department of Biostatistics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Cloughesy TF; Brain Research Institute, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Liau LM; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
  • Prins RM; Department of Neurology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA.
Neuro Oncol ; 19(6): 796-807, 2017 06 01.
Article en En | MEDLINE | ID: mdl-28115578

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 6_brain_nervous_system_cancer Asunto principal: Linfocitos Infiltrantes de Tumor / Glioblastoma / Vacunas contra el Cáncer / Células Mieloides / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 6_brain_nervous_system_cancer Asunto principal: Linfocitos Infiltrantes de Tumor / Glioblastoma / Vacunas contra el Cáncer / Células Mieloides / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
...